FIA
RXRX icon

Foundations Investment Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Foundations Investment Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-193,036
Closed -$1.27M – 880
2024
Q3 		$1.27M Buy
193,036
+38,642
+25% +$277K 0.03% 327
2024
Q2 		$1.16M Buy
154,394
+115,418
+296% +$1.01M 0.03% 313
2024
Q1 		$389K Sell
38,976
-34,682
-47% -$386K 0.01% 520
2023
Q4 		$703K Buy
73,658
+51,551
+233% +$368K 0.02% 368
2023
Q3 		$169K Sell
22,107
-896
-4% -$8.94K 0.01% 620
2023
Q2 		$172K Buy
23,003
+1,842
+9% +$12.9K 0.01% 550
2023
Q1 		$141K Buy
21,161
+4,505
+27% +$35.7K 0.01% 495
2022
Q4 		$128K Sell
16,656
-5,051
-23% -$49.5K 0.01% 429
2022
Q3 		$231K Sell
21,707
-855
-4% -$8.66K 0.01% 355
2022
Q2 		$204K Sell
22,562
-962
-4% -$6.44K 0.01% 365
2022
Q1 		$175K Buy
23,524
+7,918
+51% +$84.2K 0.01% 337
2021
Q4 		$231K Buy
15,606
+5,359
+52% +$101K 0.01% 313
2021
Q3 		$219K Buy
10,247
+3,227
+46% +$91.5K 0.01% 286
2021
Q2 		$282K Buy
+7,020
New +$208K 0.01% 246

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Foundations Investment Advisors's RXRX Position: Q4 2024 in Review

Foundations Investment Advisors sold out of Recursion Pharmaceuticals (RXRX) in Q4 2024, closing a stake of 193,036 shares — an estimated $1.27M sold.

Foundations Investment Advisors first reported a position in RXRX in Q2 2021 and held it in 14 quarters. The position peaked at $1.27M in Q3 2024. 316 funds tracked by Wall St. Rank hold RXRX as of Q4 2024.

  • Foundations Investment Advisors reported no remaining Recursion Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Foundations Investment Advisors sold 193,036 Recursion Pharmaceuticals shares in Q4 2024, an estimated $1.27M.
  • Foundations Investment Advisors first reported a position in Recursion Pharmaceuticals in Q2 2021 and held it in 14 quarters.
  • Foundations Investment Advisors's Recursion Pharmaceuticals position peaked at $1.27M in Q3 2024.
  • 316 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q4 2024.

Based on Foundations Investment Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.